Clinical Trial Update: Soy, Selenium and Breast Cancer Risk [NA]

View source ↗

Summary

A completed University of East Anglia trial investigated whether soy and selenium influence breast cancer risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Selenium (selenium)
• Soy (soy isoflavones)

Snippet

Sponsor: University of East Anglia | Conditions: Breast Cancer Risk | NA | Status: COMPLETED